Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1)

Yoshinao Ozaki; Hirotaka Imamaki; Aki Ikeda; Mitsuaki Oura; Shunsaku Nakagawa; Taro Funakoshi; Shigeki Kataoka; Yoshitaka Nishikawa; Takahiro Horimatsu; Atsushi Yonezawa; Takeshi Matsubara; Motoko Yanagita; Manabu Muto; Norihiko Watanabe

doi:10.1007/s00280-020-04193-y

Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1)

Yoshinao Ozaki, Hirotaka Imamaki, Aki Ikeda, Mitsuaki Oura, Shunsaku Nakagawa, Taro Funakoshi, Shigeki Kataoka, Yoshitaka Nishikawa, Takahiro Horimatsu, Atsushi Yonezawa, Takeshi Matsubara, Motoko Yanagita, Manabu Muto, Norihiko Watanabe

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

After publication in volume 86, issue 5, page 693–699 the author decided to opt for Open Choice and to make the article an Open Access publication.

Original language	English
Pages (from-to)	145
Number of pages	1
Journal	Cancer Chemotherapy and Pharmacology
Volume	87
Issue number	1
DOIs	https://doi.org/10.1007/s00280-020-04193-y
Publication status	Published - 2021 Jan
Externally published	Yes

ASJC Scopus subject areas

Oncology
Toxicology
Pharmacology
Cancer Research
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00280-020-04193-y

Fingerprint

Dive into the research topics of 'Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1)'. Together they form a unique fingerprint.

Cite this

Ozaki, Y., Imamaki, H., Ikeda, A., Oura, M., Nakagawa, S., Funakoshi, T., Kataoka, S., Nishikawa, Y., Horimatsu, T., Yonezawa, A., Matsubara, T., Yanagita, M., Muto, M., & Watanabe, N. (2021). Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1). Cancer Chemotherapy and Pharmacology, 87(1), 145. https://doi.org/10.1007/s00280-020-04193-y

Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1). / Ozaki, Yoshinao; Imamaki, Hirotaka; Ikeda, Aki et al.
In: Cancer Chemotherapy and Pharmacology, Vol. 87, No. 1, 01.2021, p. 145.

Research output: Contribution to journal › Comment/debate › peer-review

Ozaki, Y, Imamaki, H, Ikeda, A, Oura, M, Nakagawa, S, Funakoshi, T, Kataoka, S, Nishikawa, Y, Horimatsu, T, Yonezawa, A, Matsubara, T, Yanagita, M, Muto, M & Watanabe, N 2021, 'Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1)', Cancer Chemotherapy and Pharmacology, vol. 87, no. 1, pp. 145. https://doi.org/10.1007/s00280-020-04193-y

Ozaki Y, Imamaki H, Ikeda A, Oura M, Nakagawa S, Funakoshi T et al. Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1). Cancer Chemotherapy and Pharmacology. 2021 Jan;87(1):145. doi: 10.1007/s00280-020-04193-y

Ozaki, Yoshinao ; Imamaki, Hirotaka ; Ikeda, Aki et al. / Correction to : Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1). In: Cancer Chemotherapy and Pharmacology. 2021 ; Vol. 87, No. 1. pp. 145.

@article{2a60597f630e43988db8326b18ab736a,

title = "Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1)",

abstract = "After publication in volume 86, issue 5, page 693–699 the author decided to opt for Open Choice and to make the article an Open Access publication.",

author = "Yoshinao Ozaki and Hirotaka Imamaki and Aki Ikeda and Mitsuaki Oura and Shunsaku Nakagawa and Taro Funakoshi and Shigeki Kataoka and Yoshitaka Nishikawa and Takahiro Horimatsu and Atsushi Yonezawa and Takeshi Matsubara and Motoko Yanagita and Manabu Muto and Norihiko Watanabe",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2021",

month = jan,

doi = "10.1007/s00280-020-04193-y",

language = "English",

volume = "87",

pages = "145",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1)

AU - Ozaki, Yoshinao

AU - Imamaki, Hirotaka

AU - Ikeda, Aki

AU - Oura, Mitsuaki

AU - Nakagawa, Shunsaku

AU - Funakoshi, Taro

AU - Kataoka, Shigeki

AU - Nishikawa, Yoshitaka

AU - Horimatsu, Takahiro

AU - Yonezawa, Atsushi

AU - Matsubara, Takeshi

AU - Yanagita, Motoko

AU - Muto, Manabu

AU - Watanabe, Norihiko

PY - 2021/1

Y1 - 2021/1

N2 - After publication in volume 86, issue 5, page 693–699 the author decided to opt for Open Choice and to make the article an Open Access publication.

AB - After publication in volume 86, issue 5, page 693–699 the author decided to opt for Open Choice and to make the article an Open Access publication.

UR - http://www.scopus.com/inward/record.url?scp=85095884241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095884241&partnerID=8YFLogxK

U2 - 10.1007/s00280-020-04193-y

DO - 10.1007/s00280-020-04193-y

M3 - Comment/debate

C2 - 33180151

AN - SCOPUS:85095884241

SN - 0344-5704

VL - 87

SP - 145

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

IS - 1

ER -

Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses (Cancer Chemotherapy and Pharmacology, (2020), 86, 5, (693-699), 10.1007/s00280-020-04158-1)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this